3 research outputs found
Biochemometrics to Identify Synergists and Additives from Botanical Medicines: A Case Study with <i>Hydrastis canadensis</i> (Goldenseal)
A critical challenge in the study
of botanical natural products
is the difficulty of identifying multiple compounds that may contribute
additively, synergistically, or antagonistically to biological activity.
Herein, it is demonstrated how combining untargeted metabolomics with
synergy-directed fractionation can be effective toward accomplishing
this goal. To demonstrate this approach, an extract of the botanical
goldenseal (<i>Hydrastis canadensis)</i> was fractionated
and tested for its ability to enhance the antimicrobial activity of
the alkaloid berberine (<b>4</b>) against the pathogenic bacterium <i>Staphylococcus aureus</i>. Bioassay data were combined with
untargeted mass spectrometry-based metabolomics data sets (biochemometrics)
to produce selectivity ratio (SR) plots, which visually show which
extract components are most strongly associated with the biological
effect. Using this approach, the new flavonoid 3,3′-dihydroxy-5,7,4′-trimethoxy-6,8-<i>C</i>-dimethylflavone (<b>29</b>) was identified, as were
several flavonoids known to be active. When tested in combination
with <b>4</b>, <b>29</b> lowered the IC<sub>50</sub> of <b>4</b> from 132.2 ± 1.1 μM to 91.5 ± 1.1 μM.
In isolation, <b>29</b> did not demonstrate antimicrobial activity.
The current study highlights the importance of fractionation when
utilizing metabolomics for identifying bioactive components from botanical
extracts and demonstrates the power of SR plots to help merge and
interpret complex biological and chemical data sets
Biochemometrics for Natural Products Research: Comparison of Data Analysis Approaches and Application to Identification of Bioactive Compounds
A central challenge of natural products
research is assigning bioactive
compounds from complex mixtures. The gold standard approach to address
this challenge, bioassay-guided fractionation, is often biased toward
abundant, rather than bioactive, mixture components. This study evaluated
the combination of bioassay-guided fractionation with untargeted metabolite
profiling to improve active component identification early in the
fractionation process. Key to this methodology was statistical modeling
of the integrated biological and chemical data sets (biochemometric
analysis). Three data analysis approaches for biochemometric analysis
were compared, namely, partial least-squares loading vectors, S-plots,
and the selectivity ratio. Extracts from the endophytic fungi <i>Alternaria</i> sp. and <i>Pyrenochaeta</i> sp. with
antimicrobial activity against <i>Staphylococcus aureus</i> served as test cases. Biochemometric analysis incorporating the
selectivity ratio performed best in identifying bioactive ions from
these extracts early in the fractionation process, yielding altersetin
(<b>3</b>, MIC 0.23 μg/mL) and macrosphelide A (<b>4</b>, MIC 75 μg/mL) as antibacterial constituents from <i>Alternaria</i> sp. and <i>Pyrenochaeta</i> sp., respectively.
This study demonstrates the potential of biochemometrics coupled with
bioassay-guided fractionation to identify bioactive mixture components.
A benefit of this approach is the ability to integrate multiple stages
of fractionation and bioassay data into a single analysis
Comparison of Metabolomics Approaches for Evaluating the Variability of Complex Botanical Preparations: Green Tea (<i>Camellia sinensis</i>) as a Case Study
A challenge that must be addressed
when conducting studies with
complex natural products is how to evaluate their complexity and variability.
Traditional methods of quantifying a single or a small range of metabolites
may not capture the full chemical complexity of multiple samples.
Different metabolomics approaches were evaluated to discern how they
facilitated comparison of the chemical composition of commercial green
tea [<i>Camellia sinensis</i> (L.) Kuntze] products, with
the goal of capturing the variability of commercially used products
and selecting representative products for in vitro or clinical evaluation.
Three metabolomic-related methodsî—¸untargeted ultraperformance
liquid chromatography–mass spectrometry (UPLC-MS), targeted
UPLC-MS, and untargeted, quantitative <sup>1</sup>HNMRî—¸were
employed to characterize 34 commercially available green tea samples.
Of these methods, untargeted UPLC-MS was most effective at discriminating
between green tea, green tea supplement, and non-green-tea products.
A method using reproduced correlation coefficients calculated from
principal component analysis models was developed to quantitatively
compare differences among samples. The obtained results demonstrated
the utility of metabolomics employing UPLC-MS data for evaluating
similarities and differences between complex botanical products